SEARCH

SEARCH BY CITATION

References

  • 1
    Data from United Network for Organ Sharing. Available at http://www.unos.org. Last accessed May 2004.
  • 2
    Busuttil RW, Tanaka K. The utility of marginal donors in liver transplantation. Liver Transpl 2003; 9: 651663.
  • 3
    D'Allesandro AM, Kalayoglu M, Sollinger HW, Hoffman RM, Reed A, Knechtle S, et al. The predictive value of donor liver biopsies for the development of primary non-function after orthotopic liver transplantation. Transplantation 1991; 51: 157163.
  • 4
    Yersiz H, Shaked A, Olthoff K, Imagawa D, Shackleton C, Martin P, et al. Correlation between donor age and the pattern of liver graft recovery after transplantation. Transplantation 1995; 60: 790794.
  • 5
    Briceno J, Marchal T, Padillo J, Solorzano G, Pera C. Influence of marginal donors on liver preservation injury. Transplantation 2002; 74: 522526.
  • 6
    Dickson RC, Everhart JE, Lake JR, Wei Y, Seaberg EC, Wiesner RH, et al. Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplant Database. Gastroenterology 1997; 113: 16681674.
  • 7
    Showstack J, Katz PP, Lake JR, Brown RS, Dudley RA, Belle S, et al. Resource utilization in liver transplantation. Effects of patient characteristics and clinical practice. JAMA 1999; 281: 13811386.
  • 8
    Schnitzler MA, Woodward RS, Brennan DC, Whiting JF, Tesi RJ, Lowell JA. The economic impact of preservation time in cadaveric liver transplantation. Am J Transpl 2001; 1: 360365.
  • 9
    Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74: 11241136.
  • 10
    Lloris-Carsi JM, Cejalvo D, Toledo-Pereyra LH, Calvo MA, Suzuki S. Preconditioning: effect upon lesion modulation in warm liver ischemia. Transplant Proc 1993; 25: 33033304.
  • 11
    Peralta C, Hotter G, Closa D, Gelpi E, Bulbena O, Rosello-Catafau J. Protective effect of preconditioning on the injury associated to hepatic ischemia-reperfusion in the rat: role of nitric oxide and adenosine. Hepatology 1997; 25: 934937.
  • 12
    Lee HT, Emala CW. Protective effects of renal ischemic preconditioning and adenosine pretreatment: role of A1 and A3 receptors. Am J Physiol 2000; 278: F380F387.
  • 13
    Hotter G, Closa D, Prados M, Fernandez-Cruz L, Prats N, Gelpi E, et al. Intestinal preconditioning is mediated by a transient increase in nitric oxide. Biochem Biophys Res Commun 1996; 222: 2732.
  • 14
    Du ZY, Hicks M, Winlaw D, Spratt P, Macdonald P. Ischemic preconditioning enhances donor lung preservation in the rat. J Heart Lung Transplant 1996; 15: 12581267.
  • 15
    Clavien PA, Selzner M, Rudiger HA, Graf R, Kadry Z, Rousson V, et al. A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg 2003; 238: 843852.
  • 16
    Arai M, Thurman RG, Lemasters JJ. Ischemic preconditioning of rat livers against cold storage-reperfusion injury: role of non-parenchymal cells and the phenomenon of heterologous preconditioning. Liver Transpl 2001; 7: 292299.
  • 17
    Yin DP, Sankary HN, Chong AS, Lain-Li M, Shen J, Foster P, et al. Protective effects of ischemic preconditioning on liver preservation-reperfusion injury in rats. Transplantation 1998; 66: 152157.
  • 18
    Li SQ, Liang LJ, Huang JF, Li Z. Ischemic preconditioning protects liver from hepatectomy under hepatic inflow occlusion for hepatocellular carcinoma patients with cirrhosis. World J Gastroenterol 2004; 10: 25802584.
  • 19
    Chouker A, Schachtner T, Schauer R, Dugas M, Lohe F, Martignoni A, et al. Effects of Pringle maneuver and ischemic preconditioning on hemodynamic stability in patients undergoing elective hepatectomy: a randomized trial. Br J Anaesth 2004; 93: 204211.
  • 20
    Amador MA, Marti J, Alvarez G, Rodriguez GP, Bombuy E, Ferrer J, et al. Ischemic preconditioning during donor procurement in orthotopic liver transplantation. Preliminary results [Abstract]. 10th Annual Congress of the International Liver Transplantation Society, June 9–12, 2004, Kyoto, Japan.
  • 21
    Ploeg RJ, D'Allesandro AM, Knechtle SJ, Stegall MD, Pirsch JD, Hoffmann RM, et al. Risk factors for primary dysfunction after liver transplantation-A multivariate analysis. Transplantation 1993; 55: 807813.
  • 22
    Marino IR, Doyle HR, Aldrighetti L, Dorai C, McMichael J, Gayowski T, et al. Effect of donor age and sex on the outcome of liver transplantation. Hepatology 1995; 22: 17541762.
  • 23
    Hoofnagle JH, Lombardero M, Zetterman RK, Lake J, Porayko M, Everhart J, et al. Donor age and outcome of liver transplantation. Hepatology 1996; 24: 8996.
  • 24
    Gonzalez FX, Rimola A, Grande L, Antolin M, Garcia-Valdecasas JC, Fuster J, et al. Predictive factors of early postoperative graft function in human liver transplantation. Hepatology 1994; 20: 565573.
  • 25
    Totsuka E, Fung JJ, Urakami A, Moras N, Ishii T, Takahashi K, et al. Influence of donor cardiopulmonary arrest in human liver transplantation: possible role of ischemic preconditioning. Hepatology 2000; 31: 577580.
  • 26
    Wilson DJ, Fisher A, Das K, Goerlitz F, Holland BK, de la Torre AN, et al. Donors with cardiac arrest: improved organ recovery but no preconditioning benefit in liver allografts. Transplantation 2003; 75: 16831687.
  • 27
    Abraham S, Furth EE. Quantitative evaluation of histological features in “time zero” biopsies as predictors of rejection or graft failure: receiver-operating characteristic analysis application. Hum Pathol 1996; 27: 10771084.
  • 28
    Scheuer PJ, Lefkowitch JH. Liver biopsy interpretation. Philadelphia: W.B. Saunders, 1994: 6367.
  • 29
    Imamura H, Takayama T, Sugawara Y, Kokudo N, Aoki T, Kaneko J, et al. Pringle's manoeuvere in living donors. Lancet 2002; 360: 20492050.
  • 30
    Teoh N, Pena AD, Farrell G. Hepatic ischemic preconditioning in mice is associated with activation of NF-κB, p38 kinase, and cell cycle entry. Hepatology 2002; 36: 94102.
  • 31
    Cope JT, Mauney MC, Banks D, Binns OA, Moore CL, Rentaz JJ, et al. Intravenous phenylephrine preconditioning of cardiac grafts from non-heart beating donors. Ann Thorac Surg 1997; 63: 16641668.
  • 32
    Serafin A, Rosello-Catafau J, Prats N, Xaus C, Gelpi E, Peralta C. Ischemic preconditioning increases the tolerance of fatty liver to hepatic ischemia-reperfusion injury in the rat. Am J Pathol 2002; 161: 587601.
  • 33
    Kirsch M, Farhat F, Garnier J-P, Loisance D. Acute brain death abolishes the cardioprotective effects of ischemic preconditioning in the rabbit. Transplantation 2000; 69: 20132019.
  • 34
    Chiari P, Piriou V, Hadour G, Rodriguez C, Loufouat J, Lehot JJ, et al. Preservation of ischemia and isoflurane-induced preconditioning after brain death in rabbit hearts. Am J Physiol Heart Circ Physiol 2002; 283: H1769H1774.